Aura Health Inc. (“Aura”) (CSE: BUZZ), a publicly-listed company building an international network of cannabis assets, issued 11,493,999 units (each a “Unit” and together, the “Units”) at a price of $0.15 per unit for gross proceeds of approximately $1.7 million. Each Unit consisted of one common share in Aura and one-half of one common share purchase warrant, exercisable at $0.25 for a period of 24 months from the date of issuance. The net proceeds of the private placement will be used to further the Company’s involvement in two strategic assets in Israel.

Minden Gross LLP acted for Aura on the transaction with a team led by Andrew Elbaz (Partner, Securities & Capital Markets) and Alex Katznelson (Associate, Securities & Capital Markets).